General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a man asthma inhaler imageDecember 1 2017

NICE has published new guidelines on asthma addressing diagnosis, monitoring and the management of chronic asthma.

Asthma UK’s in-house GP, Dr Andrew Whittamore, has summarised the most significant changes for adults and children over the age of 5 years:

  • Diagnostic tests, as well as history taking, should be carried out before initiating pharmacotherapy, unless there is an urgent acute need for medication.
  • Diagnostic testing should normally use a combination of objective tests, such as spirometry, fractional exhaled nitric oxide (FeNO) and peak flow testing;
  • People who are not having symptoms controlled adequately by a steroid preventer inhaler alone should be offered an oral leukotriene receptor antagonist (LTRA) alongside a steroid preventer for 1-2 months to see if it makes a difference, rather than using a combination inhaler of a steroid and long acting beta agonist.

People who are already on a combination inhaler with well-controlled symptoms will continue their treatment.

For infants and young children, the approach to diagnosis and management will continue as a ‘trial of treatment’ with close monitoring.

The Royal College of Physicians has also flagged up another key recommendation, that of taking into account the possible reasons for uncontrolled asthma, before starting or adjusting medicines for asthma in adults, young people and children. These may include:

  • alternative diagnoses
  • lack of adherence
  • suboptimal inhaler technique
  • smoking (active or passive)
  • occupational exposures
  • psychosocial factors
  • seasonal or environmental factors.

Professor Mark Baker, director of the centre for guidelines at NICE, said: “We are recommending objective testing with spirometry and FeNO for most people with suspected asthma; a significant enhancement to current practice, which will take the NHS some time to implement, with additional infrastructure and training needed in primary care.”

The Primary Care Respiratory Society UK (PCRS) said it was “concerned that the new NICE guideline will create uncertainty for primary care clinicians, because in some areas they recommend a different approach to the BTS/SIGN (British Thoracic Society and Scottish Intercollegiate Guidelines Network) guideline, which has set the evidence based standard for the UK since 2003.”

However, the PCRS said it recognised “the importance of NICE’s incorporation of cost-effectiveness analysis, which is not addressed by BTS/SIGN.”

The British Thoracic Society said it contributed to NICE’s stakeholder consultation on these guidelines, and met with NICE earlier this year “for a useful exchange of views.” In addition: “BTS will issue a clinical response to the NICE Guidelines shortly, which we hope will be helpful to people with asthma, their carers and healthcare professional.”

Links:
NICE announcement      
NICE guideline [NG80] ‘Asthma: diagnosis, monitoring and chronic asthma management’. November 2017              
NICE Quality standard [QS25] ‘Asthma’. Published February 2013, updated November 2017           
PCRS statement                  
Asthma UK Dr Andrew Whittamore blog post       
RCP statement  
BTS/SIGN British guideline on the management of asthma               

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...